Uploaded and Shared in Youtube by: LawsuitGuru GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company's letter recommends that patients have their cholesterol and triglycerides tested prior to starting therapy with Lexiva and at periodic intervals during treatment with the drug. The letter also recommends treating lipid disorders as required, as well as monitoring and treating other risk factors for cardiovascular disease, such as hypertension, diabetes and smoking.
WHAT IS SYMPOSIER?
Symposier.com is the technological platform that will allow you (and your colleagues) to share medical information, event calendars, clinical cases, new procedures and much more with medicine professionals around the world.
Get in touch with medical professionals around the world and seize the collective experiences and knowledge to the benefit of your own patients.
Establish common-interest groups to build a collaboration network
Learn, comment and publish about local or international medical events
Seize and publish to our video, image and medical documents library
Symposier uploaded this video.
Cardiovascular Problems with Lexiva (February 2010)
Date: 04 Feb 2010
Uploader: Symposier
Lenght: 0m 44s
Specialty:
Cardiology
Pharmacology
